---
reference_id: "PMID:26631821"
title: "Kawasaki disease in adults: Observations in France and literature review."
authors:
- Fraison JB
- Sève P
- Dauphin C
- Mahr A
- Gomard-Mennesson E
- Varron L
- Pugnet G
- Landron C
- Roblot P
- Oziol E
- Chalhoub G
- Galempoix JM
- Humbert S
- Humbert P
- Sbidian E
- Grange F
- Bayrou O
- Cathebras P
- Morlat P
- Epaulard O
- Pavese P
- Huong du LT
- Zoulim A
- Stankovic K
- Bachelez H
- Smail A
- Bachmeyer C
- Granel B
- Serratrice J
- Brinchault G
- Mekinian A
- Costedoat-Chalumeau N
- Bourgarit-Durand A
- Puéchal X
- Guillevin L
- Piram M
- Koné-Paut I
- Fain O
- CRI and the French Vasculitis Study Group
journal: Autoimmun Rev
year: '2016'
doi: 10.1016/j.autrev.2015.11.010
content_type: abstract_only
---

# Kawasaki disease in adults: Observations in France and literature review.
**Authors:** Fraison JB, Sève P, Dauphin C, Mahr A, Gomard-Mennesson E, Varron L, Pugnet G, Landron C, Roblot P, Oziol E, Chalhoub G, Galempoix JM, Humbert S, Humbert P, Sbidian E, Grange F, Bayrou O, Cathebras P, Morlat P, Epaulard O, Pavese P, Huong du LT, Zoulim A, Stankovic K, Bachelez H, Smail A, Bachmeyer C, Granel B, Serratrice J, Brinchault G, Mekinian A, Costedoat-Chalumeau N, Bourgarit-Durand A, Puéchal X, Guillevin L, Piram M, Koné-Paut I, Fain O, CRI and the French Vasculitis Study Group
**Journal:** Autoimmun Rev (2016)
**DOI:** [10.1016/j.autrev.2015.11.010](https://doi.org/10.1016/j.autrev.2015.11.010)

## Content

1. Autoimmun Rev. 2016 Mar;15(3):242-9. doi: 10.1016/j.autrev.2015.11.010. Epub 
2015 Nov 26.

Kawasaki disease in adults: Observations in France and literature review.

Fraison JB(1), Sève P(2), Dauphin C(3), Mahr A(4), Gomard-Mennesson E(5), Varron 
L(6), Pugnet G(7), Landron C(8), Roblot P(8), Oziol E(5), Chalhoub G(9), 
Galempoix JM(10), Humbert S(11), Humbert P(12), Sbidian E(13), Grange F(14), 
Bayrou O(15), Cathebras P(16), Morlat P(17), Epaulard O(18), Pavese P(18), Huong 
du LT(19), Zoulim A(20), Stankovic K(21), Bachelez H(22), Smail A(23), Bachmeyer 
C(24), Granel B(25), Serratrice J(25), Brinchault G(26), Mekinian A(27), 
Costedoat-Chalumeau N(28), Bourgarit-Durand A(29), Puéchal X(28), Guillevin 
L(28), Piram M(30), Koné-Paut I(30), Fain O(27); CRI and the French Vasculitis 
Study Group.

Author information:
(1)Service de Médecine Interne, Hôpital Saint Louis, AP HP, Université Diderot, 
France. Electronic address: jeanbaptiste.fraison@aphp.fr.
(2)Service de Médecine Interne, Hôpital de la Croix Rousse, Centre Hospitalier 
Universitaire de Lyon, Université de Lyon, France.
(3)Service de Cardiologie, Hôpital Gabriel Montpied, Université de 
Clermont-Ferrand, France.
(4)Service de Médecine Interne, Hôpital Saint Louis, AP HP, Université Diderot, 
France.
(5)Service de Médecine Interne, Centre Hospitalier de Béziers, France.
(6)Service de Médecine Interne, Centre Hospitalier de Montélimar, France.
(7)Service de Médecine Interne, Centre Hospitalier Universitaire de Toulouse, 
France.
(8)Service de Médecine Interne et Maladies Infectieuses, Centre Hospitalier 
Universitaire de Poitiers, France.
(9)Service de Médecine Interne, Centre Hospitalier de Metz-Thionville, France.
(10)Service de Médecine Interne, Centre Hospitalier de Charleville-Mézières, 
France.
(11)Service de Médecine Interne, Centre Hospitalier Universitaire de Besançon, 
France.
(12)Service de Dermatologie, Centre Hospitalier Universitaire de Besançon, 
University of Franche-Comté, INSERM UMR1098, SFR FED 4234 IBCT, Besançon, 
France.
(13)Service de Dermatologie, Hôpital Henri Mondor, AP HP, Université Paris Est, 
France.
(14)Service de Dermatologie, Centre Hospitalier Universitaire de Reims, France.
(15)Service de Dermatologie, Hôpital Tenon, AP HP, Université Pierre et Marie 
Curie, France.
(16)Service de Médecine Interne, Centre Hospitalier Universitaire de St Etienne, 
France.
(17)Service de Médecine Interne et Maladies Infectieuses, Centre Hospitalier 
Universitaire de Bordeaux, France.
(18)Service de Maladies Infectieuses, Centre Hospitalier Universitaire de 
Grenoble, France.
(19)Service de Médecine Interne 2, Hôpital La Pitié-Salpétrière, AP HP, 
Université Pierre et Marie Curie, France.
(20)Service de Médecine Interne, Centre Hospitalier Universitaire de Caen, 
France.
(21)Service de Médecine Interne, Hôpital Tenon, AP HP, Université Pierre et 
Marie Curie, France.
(22)Service de Dermatologie, Hôpital Saint Louis, AP HP, Université Diderot, 
France.
(23)Service de Médecine Interne, Centre Hospitalier Universitaire d'Amiens, 
France.
(24)Service de Médecine Interne, Centre Hospitalier de Creil, France.
(25)Service de Médecine Interne, Hôpital Nord, AP HM, France.
(26)Service de Pneumologie, Centre Hospitalier Universitaire de Rennes, France.
(27)Service de Médecine Interne, DHUi2B, Hôpital Saint Antoine, AP HP, 
Université Pierre et Marie Curie, France.
(28)Service de Médecine Interne, Hôpital Cochin, Centre de Référence Maladies 
Systémiques et Autoimmunes Rares, AP HP, Université Paris Descartes, France.
(29)Service de Médecine Interne, Hôpital Jean Verdier, AP HP, Université Leonard 
de Vinci, France.
(30)Service de Rhumatologie Pédiatrique, Centre de Référence des Maladies 
Auto-Inflammatoires de l'enfant, Hôpital Bicêtre, AP HP, Université Paris Sud, 
France.

OBJECTIVE: Kawasaki disease (KD) is a vasculitis that mostly occurs in young 
children and rarely in adults. We analyzed the characteristics of adult-onset KD 
(AKD) in France.
METHODS: We collected retrospective and prospective data for patients with a 
diagnosis of KD occurring after the age of 18 years. Cases were obtained via 
various French medical networks and identified from the international 
literature.
RESULTS: We included 43 patients of AKD at 26 institution from 1992 to 2015, 
with mean (SD) age 30 (11) years (range 18-68) and sex ratio (M/F) 1.2; 34 
patients met the American Heart Association criteria and 9 were incomplete AKD. 
The median time to diagnosis was 13 days (interquartile range 8-21). The main 
symptoms were fever (100%), exanthema (98%), changes in the extremities (91%), 
conjunctivitis (77%), oral cavity changes (89%), cervical adenitis (55%) and 
cardiac abnormalities (45%). Overall, 35% of patients showed large-vessel 
vasculitis: coronary vasculitis (26%) and coronary aneurysm (19%). Treatment was 
mostly intravenous immunoglobulins (79%) and aspirin (81%). Four patients showed 
myocardial infarction due to coronary vasculitis, but none were treated with 
IVIg because of late diagnosis. After a median follow-up of 5 months (range 
1-117), persistent aneurysm was noted in 9% of cases. Damage was significantly 
lower with early treatment than late or no treatment (p=0.01).
CONCLUSION: Given the high frequency of cardiac involvement and complications in 
this series of AKD, diagnosis and treatment should not be delayed, and early 
IVIg treatment seems to improve the outcome.

Copyright © 2015 Elsevier B.V. All rights reserved.

DOI: 10.1016/j.autrev.2015.11.010
PMID: 26631821 [Indexed for MEDLINE]